Evidence map›Paper›PMID 20820974›Full record

ReviewJournal of cardiovascular translational research2010

Molecular changes occurring during reverse remodelling following left ventricular assist device support.

Emma J Birks, Robert S George

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of cardiovascular translational research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Treatment strategies for myocardial recovery in heart failure.Current treatment options in cardiovascular medicine · 2014
    Article
  5. Review
  6. Follistatin-like 3 mediates paracrine fibroblast activation by cardiomyocytes.Journal of cardiovascular translational research · 2012
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Emma J BirksTransplantation and Mechanical Support, University of Louisville, 201 Abraham Flexner Way, Louisville, KY 40222, USA. e.birks@imperial.ac.uk
Robert S George

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Remodelling is the central feature that occurs in the progression of heart failure. However, unloading of the heart with a left ventricular assist device (LVAD) can lead to reversal of many of the remodelling changes even in patients with advanced heart failure. LVAD unloading can also lead to improved myocardial function and this improvement can be sufficient to allow removal of the device leaving the patient to lead a normal life. We review the molecular changes that have been demonstrated with LVAD unloading in patients bridged to transplantation and also those that have occurred in the myocardium of patients that have recovered their myocardial function enough to have the device removed. Changes in both the myocyte and the matrix are reviewed.

Indexed as

Heart-Assist DevicesVentricular RemodelingAnimalsDevice RemovalExtracellular MatrixHeart FailureHumansMyocytes, CardiacRecovery of FunctionTime FactorsTreatment Outcome

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.